Abstract
The author has updated the Acknowledgment Section of the article published in Current Alzheimer Research Volume 16, No. 3, 2019, pp. 209-218. Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease
Acknowledgements:
This work was supported by grant PRELUDIUM no. 2015/19/N/NZ3/00055 from the Polish National Science Centre, grant of Medical University of Lodz no. 502-03/5-108-05/502-54-194, grant OPUS no. 2016/21/B/NZ5/01411 from the Polish National Science Centre, grant HARMONIA no. 2013/10/M/NZ1/00280 and grant of Medical University of Lodz, Poland no. 502- 03/5-108-05/502-54-224-18.
Current Alzheimer Research
Title:Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease
Volume: 16 Issue: 6
Author(s): Wioletta Rozpędek, Dariusz Pytel, Tomasz Popławski, Anna Walczak, Kinga Gradzik and Adam Wawrzynkiewicz
Affiliation:
Abstract:
The author has updated the Acknowledgment Section of the article published in Current Alzheimer Research Volume 16, No. 3, 2019, pp. 209-218. Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease
Acknowledgements:
This work was supported by grant PRELUDIUM no. 2015/19/N/NZ3/00055 from the Polish National Science Centre, grant of Medical University of Lodz no. 502-03/5-108-05/502-54-194, grant OPUS no. 2016/21/B/NZ5/01411 from the Polish National Science Centre, grant HARMONIA no. 2013/10/M/NZ1/00280 and grant of Medical University of Lodz, Poland no. 502- 03/5-108-05/502-54-224-18.
Export Options
About this article
Cite this article as:
Rozpędek Wioletta , Pytel Dariusz , Popławski Tomasz, Walczak Anna , Gradzik Kinga and Wawrzynkiewicz Adam , Inhibition of the PERK-dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer’s Disease, Current Alzheimer Research 2019; 16 (6) . https://dx.doi.org/10.2174/156720501606190723163906
DOI https://dx.doi.org/10.2174/156720501606190723163906 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers
Current Molecular Pharmacology Cytokine and Nitric Oxide Production Following Severe Envenomation
Current Drug Targets - Inflammation & Allergy Editorial [ Role of Ion Channels in Neurological Disorders Guest Editor: Johannes J. Krupp ]
CNS & Neurological Disorders - Drug Targets Investigating Optimal Echo Times for Quantitative Susceptibility Mapping of Basal Ganglia Nuclei in the Healthy Brain
Current Medical Imaging Specific Nutritional Supplement (Supportan<sup>®</sup>) in the Supportive Care of the Radio-Chemotherapy Treatment of Head and Neck Cancers: Biochemical Parameters. Preliminary Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Is Mania the Hypertension of the Mood? Discussion of A Hypothesis
Current Neuropharmacology Chemistry, Physiology, and Pharmacology of β-Adrenergic Mechanisms in the Heart. Why are β-Blocker Antiarrhythmics Superior?
Current Pharmaceutical Design Drug Discovery: Methods for Identifying New Drug Targets
Drug Design Reviews - Online (Discontinued) The First Approved Agent in the Glitazar’s Class: Saroglitazar
Current Drug Targets Preface [Hot Topic: New Clinical Applications for Naturally Occurring Peptide Toxins (Guest Editors: Robert Jones / Graeme Semple)]
Current Medicinal Chemistry Interplay between Catalysts and Substrates for Activity of Class Ib Aminoacyl-tRNA Synthetases and Implications for Pharmacology
Current Topics in Medicinal Chemistry Protein Conformational Misfolding and Amyloid Formation: Characteristics of a New Class of Disorders that Include Alzheimers and Prion Diseases
Current Medicinal Chemistry Disaggregation of Tau as a Therapeutic Approach to Tauopathies
Current Alzheimer Research Low-Dose Radiation Stimulates Wnt/β-Catenin Signaling, Neural Stem Cell Proliferation and Neurogenesis of the Mouse Hippocampus in vitro and in vivo
Current Alzheimer Research Ginkgo Biloba Extract (EGb 761) in Alzheimers Disease: Is there Any Evidence?
Current Alzheimer Research Structural Activity Relationship and Importance of Benzothiazole Derivatives in Medicinal Chemistry: A Comprehensive Review
Mini-Reviews in Organic Chemistry Preparing for Pregnancy: A Body Weight Perspective and Update of the Literature
Current Nutrition & Food Science Thirty Years of Dutch Drugs and Driving Research: Strengths and Limitations of the On-The-Road Highway Driving Test and Future Challenges
Current Psychopharmacology Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents
Anti-Cancer Agents in Medicinal Chemistry Targeting Insulin Amyloid Assembly by Aminosugars and Their Derivatives
Protein & Peptide Letters